Centers for Disease Control. Bacterial meningitis and meningococcaemia – United States, 1978. MMWR1979; 28:277–9.
2.
SchlechWF, WardJI, BandJD, HightowerA. Bacterial meningitis in the United States. 1978 through 1981: the National Bacterial Meningitis Surveillance Study. JAMA1985; 253:1749–54.
3.
WengerJD, HightowerAW, FacklamRR. Bacterial Meningitis Study Group. Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. J Infect Dis1990; 162:1316–23.
4.
SellSH. Long-term sequelae of bacterial meningitis in children. Paediatr Infect Dis1983; 2:90–3.
5.
PomeroySL, HolmesSJ, DodgePR. Seizures and other neurologic sequelae of bacterial meningitis in Children. N Engl J Med1990; 323:1651–57.
6.
KleinJO, FeiginRD, McCrackenGHJr. Report of the task force on diagnosis and management of meningitis. Paediatrics1986; 7895 (Pt 2):959–82.
7.
DurandML, CalderwoodSB, WeberDJ. Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med1993; 328:21–8.
8.
QuagliarelloVQ, ScheldWM. Bacterial meningitis: pathogenesis, pathophysiology, and progress. N Engl J Med1992; 327:864–72.
9.
TunkelAR, WispelweyB, SchelsWM. Bacterial meningitis: recent advances in pathophysiology and treatment. Ann Intern Med1990; 112:610–23.
10.
Saez-llorensX, RamiloO, MustafaMM. Molecular pathophysiology of bacterial meningitis: current concepts and therapeutic implications. J Paediatr1990; 327: 864–72.
TownsendGC, ScheldWM. Adjunctive therapy for bacterial meningitis: rationale for use, current status and prospects for the future. Clin Infect Dis1993; 17 (Suppl. 2):S537–49.
13.
MingWJ, BersaniL, MontovaniA. Tumour necrosis factor is chemotactic for monocytes and polymorphonuclear leucocytes. J Immunol1987; 138:1469–74.
14.
TraceyKJ, LowrySF, CeremiA. Cachectin: A hormone that triggers acute shock and chronic cachexia. J Infect1988; 157:413–20.
15.
DinarelloCA. An update on human interleukin-1: from molecular biology to clinical relevance. J Clin Immunol1985; 5:287–97.
16.
ArditiM, ManogueKR, CaplanM. Cerebrospinal fluid cachectin/tumour necrosis factor-a and platelet activating factor concentrations and severity of bacterial meningitis in children. J Infect Dis1990; 162:139–47.
17.
MustafaMM, LebelMH, RamiloO. Correlation of interleukin 1-b and cachectin concentrations in cerebrospinal fluid and outcome from bacterial meningitis. J Paediatr1989; 115:208–13.
18.
TauberMG, ShiblAM, HackbarthCJ. Antibiotic therapy, endotoxin concentration in the cerebrospinal spinal fluid, and brain edema in experimental E. coli meningitis in rabbits. J infect Dis1987; 156:456–62.
19.
TuoamenE, HengstlerB, RichR. Nonsteroidal anti-inflammatory agents in the therapy of experimental pneumococcal meningitis. J Infect Dis1987; 155:985–90.
20.
MustafaMM, RamiloO, MertsolaJ. Modulation of inflammation and cachectin activity in relation to treatment of experimental Haemophilus influenza type b meningitis. J Infect Dis1989; 160:818–25.
21.
BeutlerB, KrochinN, MilsarkIW. Control of cachectin (tumour necrosis factor) synthesis; mechanisms of endotoxin resistance. Science1986; 232:977–80.
22.
LeeSW, TsouA-P, ChanH. Glucocorticoids selectively inhibit the transcription of the interleukin-1 B gene and decrease the stability of interleukin-1B mRNA. Proc Natl Acad Sci USA1988; 85:1204–8.
23.
KatoK, YokoiT, TakanoN. Detection by in situ hybridisation and phenotypic characterisation of cells expressing IL-6 m-RNA in human stimulated blood. J Immunol1990; 144:317–22.
24.
KadurugamuwaJL, HegstlerB, ZakO. Effects of anti-inflammatory drugs on arachidonic acid metabolites and cerebrospinal fluid proteins during infectious pneumococcal meningitis in rabbits. Paediatr Infect Dis1987; 6:1153–4.
25.
FishmanRA. Steroids in the treatment of brain oedema (editorial). N Engl J Med1982; 306:359–60.
NolanCM, McAllisterCK, WaltersE. Experimental pneumococcal meningitis. IV. The effect of methyl-prednisolone on meningeal inflammation. J Lab Clin Med1978; 91:979–88.
28.
ScheldWM, DaceyRG, WinnHR. Cerebrospinal fluid outflow resistance in rabbits with experimental meningitis. Alterations with penicillin and methylprednisolone. J Clin Invest1980; 66:243–53.
29.
TauberMG, Khayam-BashiH, SandeMA. Effects of ampicillin and corticosteroids on brain water content, cerebrospinal fluid pressure and cerebrospinal fluid lactate levels in experimental pneumococcal meningitis. J Infect Dis1985; 151:528–34.
30.
MustafaMM, RamiloO, MertsolaJ. Modulation of inflammation and cachectin activity in relation to treatment of experimental Haemophilus influenza type b meningitis. J Infect Dis1989; 160:818–25.
31.
ScheldWM, BrodeurJ. Effect of methylprednisolone on entry of ampicillin and gentamicin into cerebrospinal fluid in experimental pneumococcal and Escherichia coli meningitis. Antimicrob Agents Chemother1983; 23:108–12.
32.
RodriguezAF, KaplanSL, HawkinsEP. Effect of dexamethasone or HWA-1138 in combination with antibiotics in experimental Haemophilus influenzae type b infection. Antimicrob Agents Chemother1991; 35:1980–4.
33.
ParisMM, HickeySM, Uscher. Effect of dexamethasone on therapy of experimental penicillin and cephalosporin resistant pneumococcal meningitis. Antimicrob Agents Chemother1994; 38:1320–4.
34.
GaillardJL, AbadieV, CheronG. Concentrations of ceftriaxone in cerebrospinal fluid of children with meningitis receiving dexamethasone therapy. Antimicrob Agents Chemother1994; 38:1209–10.
35.
LebelMH, FreijBJ, SyrogiannopoulosGA. Dexa-methasone therapy for bacterial meningitis. Results of two double-blind, placebo controlled trials. N Engl J Med1988; 319:964–71.
36.
LebelMH, HoytMJ, WaagnerDC. Magnetic resonance imaging and dexamethasone therapy for bacterial meningitis. Am J Dis Child1989; 143:301–6.
37.
GirgisNI, FaridZ, MikhailIA. Dexamethasone treatment for bacterial meningitis in children and adults. Ped Infect Dis J1989; 8:848–51.
38.
OdioCM, FaingezichtI, ParisM. The beneficial effects of early administration in infants and children with bacterial meningitis. N Engl J Med1991; 324:1525–31.
39.
SchaadUB, LipsU, GnehmHE. Dexamethasone therapy for bacterial meningitis in children. Lancet1993; 342:457–61.
40.
KilpiT, PeltolaH, JauhiainenT. Oral glycerol and intravenous dexamethasone in preventing neurologic and audiologic sequelae of childhood bacterial meningitis. Paediatr Infect Dis J1995; 14:270–8.
41.
WaldE, KaplanS, MasonE. Dexamethasone for children with bacterial meningitis. Paediatrics1995; 95:21–8.
42.
KanraGY, OzenH, SecmeerG. Beneficial effects of dexamethasone in children with pneumococcal meningitis. Paediatr Infect Dis J1995; 14:490–4.
43.
McIntyrePB, BerkeyCS, KingS. Dexamethasone as adjunctive therapy in Bacterial Meningitis. A meta-analysis of randomised clinical trials since 1988. JAMA1997; 278:925–31.
44.
KennedyWA, HoytMJ, McCrackenGHJr. The role of corticosteroid therapy in children with pneumococcal meningitis. Am J Dis Child1991; 145:1374–8.
45.
Saez-LlorensX, RamiloO, MustafaMM. Molecular pathophysiology of bacterial meningitis; current concepts and therapeutic implications. J Paediatr1990; 116:671–84.
46.
TunkelAR, WispelwayB, ScheldWM. Bacterial meningitis; recent advances in pathophysiology and treatment. Ann Intern Med1990; 112:6110–23.
47.
WaagnerDC, KennedyWA, HoytMJ. Lack of adverse effects of dexamethasone therapy in aseptic meningitis. Paediatr Infect Dis J1990; 9:922–3.
48.
DooleyDP, CarpenterJL, RademacherS. Adjunctive corticosteroid therapy for tuberculosis: a critical reappraisal of the literature. Clin Infect Dis1997; 25:872–87.
49.
O'TooleRD, ThorntonGF, MkMukherjee. Dexa-methasone in tuberculous meningitis; relationship of cerebrospinal fluid effects in therapeutic efficacy. Ann Intern Med1969; 70:39–48.
50.
AshbyM, GrantH. Tuberculous meningitis treated with cortisone. Lancet1955; 1: 65–6. 51 Kaojarern S, Supmonchai K, Phuapradt P et al. Effect of steroids on cerebrospinal fluid penetration of antituberculous drugs in tuberculous meningitis. Clin Pharm Ther 1991; 49:6–12.
51.
EscobarJA, BelseyMA, DuenasA. Mortality from tuberculous meningitis reduced by steroid therapy. Paediatrics1975; 56:1050–5.
SchoemanJF, Van ZylLE, LanbscherSA. Effect of corticosteroids in intracranial pressure, computed tomographic findings and clinical outcome in young children with tuberculous meningitis. Paediatrics1997; 99:226–31.
54.
ShaoPP. Clinical analysis of 445 adult cases of tuberculous meningitis. Chi J Tuberc Respir Dis1980; 3:131–2.
55.
Streptomycin in tuberculosis trials committee. Medical Research Council. Streptomycin treatment of tuberculous meningitis. Lancet1948; 1:582–97.
56.
MukaiK, YasudaT, HaraK. Adult pneumococcal meningitis complicated by cerebral infarction: a case report. Rinsho Shinkeigaku - Clinical neurology1996; 36:1110–3.
57.
SyrogiannopoulosGA, OlsenKD, McCrackenGHJr. Mannitol treatment in experimental Haemophilus influenza type b meningitis. Paediatr Res1987; 22:118–22.
58.
LorenzlS, KoedelU, PfisterHW. Mannitol but not allopurinol, modulates changes in cerebral blood flow, intracranial pressure and brain water content during pneumococcal meningitis in the rat. Crit Care Med1996; 24:1874–80.